In this work, the ferroelectricity of hafnium zirconium oxide (HfZrO, HZO) is enhanced by fluorine (F)-plasma treatment, which is used to fabricate MoS negative-capacitance field-effect transistor. Measurements show that the subthreshold swing of the transistor is significantly reduced to 17.8 mV dec over almost four orders of output current, as compared to its counterpart without the F-plasma treatment (37.4 mV dec). The involved mechanism is that during the F-plasma treatment, F atoms can be incorporated into the HZO bulk to passive its oxygen vacancies and interface traps, thus forming robust Zr-F and Hf-F bonds. Therefore, the F-plasma-treated HZO film exhibits much less oxygen vacancies than the untreated HZO film, which is beneficial to enhancing the amplification effect on the surface potential of the MoS channel during the NC operation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1088/1361-6528/abe0e3 | DOI Listing |
J Mater Sci Mater Med
August 2021
Department of Physics, Cochin University of Science and Technology, Cochin, Kerala, 682022, India.
Surface modification of superparamagnetic FeO nanoparticles using polymers (polyaniline/polypyrrole) was done by radio frequency (r.f.) plasma polymerization technique and characterized by XRD, TEM, TG/DTA and VSM.
View Article and Find Full Text PDFNanotechnology
May 2021
Department of Electrical and Electronic Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong, People's Republic of China.
In this work, the ferroelectricity of hafnium zirconium oxide (HfZrO, HZO) is enhanced by fluorine (F)-plasma treatment, which is used to fabricate MoS negative-capacitance field-effect transistor. Measurements show that the subthreshold swing of the transistor is significantly reduced to 17.8 mV dec over almost four orders of output current, as compared to its counterpart without the F-plasma treatment (37.
View Article and Find Full Text PDFJ Antimicrob Chemother
January 2019
Novartis Institutes for BioMedical Research, Emeryville, CA, USA.
Objectives: The neutropenic murine thigh infection model and a dose-fractionation approach were used to determine the pharmacokinetic/pharmacodynamic (PK/PD) relationship of LYS228, a novel monobactam antibiotic with activity against Enterobacteriaceae including carbapenem-resistant strains.
Methods: Mice (n = 4 per group) were inoculated with Enterobacteriaceae strains via intramuscular injection. Two hours post-bacterial inoculation, treatment with LYS228 was initiated.
Cardiovasc Intervent Radiol
December 2018
Department of Radiology, Faculty of Medicine, Shimane University, P.O. Box 00693-8501, 89-1 Enya cho, Izumo, Japan.
Purpose: To evaluate the utility of future liver remnant plasma clearance rate of indocyanine green (ICGK-F) for predicting post-hepatectomy liver failure (PHLF) compared with percentage future liver remnant volume-to-total liver volume ratio (%FLR) after portal vein embolization (PVE).
Materials And Methods: PVE procedures in 20 patients (15 patients underwent PVE with absolute ethanol; 5 patients with gelatin particles) from 2010 to 2017 were analyzed. %FLR = future liver remnant volume (ml)/[total liver volume (ml) - tumor volume (ml)] × 100; ICGK-F = plasma clearance rate of indocyanine green (ICGK) × %FLR/100 were calculated before and after PVE.
Br J Clin Pharmacol
July 2017
Department of Transplant Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Aims: Tacrolimus is a cornerstone in modern immunosuppressive therapy after kidney transplantation. Tacrolimus dosing is challenged by considerable pharmacokinetic variability, both between patients and over time after transplantation, partly due to variability in cytochrome P450 3A (CYP3A) activity. The aim of this study was to assess the value of the endogenous CYP3A marker 4β-hydroxycholesterol (4βOHC) for tacrolimus dose individualization early after kidney transplantation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!